Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?

1,627 Followers

Akebia Therapeutics (AKBA) Ownership Overview

2.85% Insiders

9.47% Mutual Funds

2.53% Other Institutional Investors

13.80% ETFs

71.35% Public Companies and Individual Investors

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 25.80% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 71.35% is owned by Public Companies and Individual Investors.

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 12.00% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 13.80% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	John P. Butler	xxxxxxxxxxxxx	$86588

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$205276
Dec 31, 2025	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$606268

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
12,981,464	Institution	4.85%	19,602,011
10,795,143	Institution	4.03%	16,300,666
9,948,658	Institution	3.71%	15,022,474
8,736,300	Institution	3.26%	13,191,813
3,526,992	Insider	1.32%	5,325,758
2,821,433	Institution	1.05%	4,260,364
2,595,691	Institution	0.97%	3,919,493
2,158,527	Institution	0.81%	3,259,376
1,442,041	Institution	0.54%	2,177,482
1,417,532	Institution	0.53%	2,140,473

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
10,795,143	Institution	4.03%	16,300,666
2,821,433	Institution	1.05%	4,260,364
2,595,691	Institution	0.97%	3,919,493
2,158,527	Institution	0.81%	3,259,376
1,417,532	Institution	0.53%	2,140,473
763,489	Institution	0.29%	1,152,868
746,039	Institution	0.28%	1,126,519
720,848	Institution	0.27%	1,088,480
705,736	Institution	0.26%	1,065,661
501,389	Institution	0.19%	757,097

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	7,912,283	Institution	2.95%	11,156,319
SPDR S&P BIOTECH ETF	7,799,232	Institution	2.91%	11,386,879
iShares Russell 2000 ETF	6,142,914	Institution	2.29%	8,968,654
Vanguard Extended Market ETF	2,898,377	Institution	1.08%	4,086,712
iShares Russell 2000 Value ETF	1,973,965	Institution	0.74%	2,881,989
Schwab U.S. Small-Cap ETF	1,282,677	Institution	0.48%	1,872,708
Vanguard Russell 2000 ETF	1,251,224	Institution	0.47%	1,639,103
Fidelity Enhanced Small Cap ETF	1,141,831	Institution	0.43%	1,667,073
Vanguard Health Care ETF	762,130	Institution	0.28%	1,074,603
iShares Micro-Cap ETF	665,130	Institution	0.25%	971,090

FAQ

Who Owns Akebia Therapeutics (AKBA)?

According to the latest TipRanks data, approximately 2.53% of the company's stock is held by institutional investors, 2.85% is held by insiders, and 71.35% is held by retail investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.53% of Akebia Therapeutics (AKBA) stock is held by institutional investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?

According to the latest TipRanks data, approximately 71.35% of Akebia Therapeutics (AKBA) stock is held by retail investors.

Who owns the most shares of Akebia Therapeutics (AKBA)?

Vanguard owns the most shares of Akebia Therapeutics (AKBA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.